Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-012217
Filing Date
2012-02-22
Accepted
2012-02-22 18:49:59
Documents
1
Period of Report
2012-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3316
  Complete submission text file 0001209191-12-012217.txt   4783
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address 21 PENNIMAN RD BROOKLINE MA 02445-4122
Business Address
BELBEL CAESAR J (Reporting) CIK: 0001109753 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 12631671